Now, local pharmaceutical companies have begun producing modern therapies inside the country, offering fresh hope to millions.
Recent reports suggest that nearly one in three adults in Pakistan is living with diabetes. According to the International Diabetes Federation and the World Health Organization, about 34.5 million Pakistanis are currently affected by the disease. Alarmingly, more than nine million people still do not know they have it, silently carrying the risk of severe complications.
To address this growing health crisis, several pharmaceutical companies have introduced new medications based on GLP 1 and GIP hormone pathways. These therapies work in a smarter way than many traditional drugs. They help the body release insulin more effectively, slow down digestion, and gently reduce appetite a triple action that targets both diabetes and obesity.
Some of the well known medicines already available in Pakistan include Ozempic and Mounjaro. These treatments are usually given as a once weekly injection, although tablet forms for daily use also exist. Doctors say these drugs can help patients control blood sugar while also shedding excess weight.
Until recently, imported versions of these medicines were painfully expensive costing between 150,000 and 300,000 Pakistani rupees for a course. Now, locally produced options are entering the market at around 5,000 to 15,000 rupees for a four-dose pack, making them far more accessible.
Health experts believe this price shift could be a game changer. Dr. Qaiser Waheed, a former chairman of the Pakistan Pharmaceutical Manufacturers Association, says the country’s pharmaceutical industry is trying to close the gap between medical innovation and patient access.
According to him, the new drugs are being introduced only after approval from the Drug Regulatory Authority of Pakistan, which allows medicines already cleared by strict international regulators.
Yet doctors warn that medicine alone cannot solve the problem. Dr. Muhammad Ali Arif, a professor of medicine and a specialist in diabetes and obesity, explains that insulin resistance lies at the heart of type 2 diabetes. In simple terms, the body still produces insulin, but it does not use it effectively. Excess body weight, especially obesity, is one of the strongest triggers behind this condition.
Pakistan’s changing lifestyle is making the situation worse. Diets rich in refined carbohydrates, fried foods, and sugary drinks, combined with low physical activity, are quietly fueling the epidemic.
Experts argue that tackling diabetes requires more than prescriptions. It calls for a shift in daily habits healthier food choices, regular walks, and better awareness starting from childhood.
Even public figures are proving that change is possible. Legendary cricketer Wasim Akram, who lives with diabetes, has often spoken about managing the condition through balanced eating, discipline, and exercise.
As Pakistan moves toward producing modern diabetes drugs at home, many hope this step will not only lower costs but also spark a broader conversation about prevention. After all, doctors say, the real victory against diabetes begins long before the first injection, it begins with how we live every day.
